LIVE ONLINE 24 February 2022

Pharma Sustainability Integrates 2022 Agenda

24 Feb 2022

KEYNOTES, PANEL DISCUSSIONS AND PRESENTATIONS

THE DAY WILL START WITH OPENING REMARKS AND CONCLUDE AT 14:20.

11:00 – 11:07

Welcome and opening remarks

ALIX MACKAY MRSC | Director | The Life Sciences Marketing Academy

Session 1

11:10 – 11:31

Policy – Learning from COP26

The COP26 conference united the world to tackle climate change. How can life sciences take the learnings from COP26 forward for the sector?

speakers

Session 2

11:31 – 11:36

Decarbonising Pharma supply chains

COP26 identified a requirement for a serious step change in commitment to decarbonisation. Supply chains will come under increasing environmental scrutiny driven by regulation, investors and market demand. This poses a number of challenges and opportunities to the Pharma & Life Sciences sector.

Presented by PwC

Session 3

11:40 – 12:25

Industry Ambition Roundtable

Sustainability in practice – How is the pharmaceutical industry answering sustainability challenges.

speakers

Session 4

12:30 – 12:43

Carbon Footprint Showcase:

A presentation on sustainable healthcare

FIONA ADSHEAD | Chair | Sustainable Healthcare Coalition

12:48 – 13:01

Supply Chain Showcase:

A presentation on the challenges and opportunities sustainability offers the Pharma supply chain.

NAZNEEN RAHMAN CBE | Founder and Chief Executive Officer | YewMaker

13:06 – 13:51

Pharma Supply Chain Roundtable

How can collaboration across the supply chain harness innovation to drive sustainability benefits in pharma development, manufacturing and supply?

speakers

Session 7

13:56 – 14:09

Manufacturing showcase:

A presentation on achieving sustainable pharmaceutical manufacturing.

CHRIS PRICE | Professor of Industrial Crystallization and Isolation | University of Strathclyde

14:15 – 14:28

Manufacturing showcase:

A presentation on oligonucleotides

JOHN ARTHUR | Director | Medicines Manufacturing Innovation Centre

14:32 – 14:38

How CPI supports the pharma industry to be more sustainable

FRANK MILLAR | Chief Executive | CPI

Policy:

IVAN McKEE | Minister for Business, Trade, Tourism and Enterprise, will will provide a Scottish Government perspective on how the Scottish Life Sciences sector is supporting sustainable healthcare.

The conference ends with a final few words from Alix Mackay.

11:00 – 11:04

Welcome and opening remarks

Session 1:

11:05 – 11:31

Policy – Learning from COP26

How we can learn from COP26? With input from Government, ABPI, Pharma and Academia

speakers

Session 2:

11:31 – 11:36

A Sustainability Presentation

Presented by PwC

Session 3:

11:40 – 12:25

Industry ambition

Sustainability in practice – How is the pharmaceutical industry answering sustainability challenges.

speakers

Session 4:

12:30 – 12:43

Carbon Footprint Showcase

A presentation on sustainable healthcare

FIONA ADSHEAD | Chair | Sustainable Healthcare Coalition

12:48 – 13:01

Supply Chain Showcase

A presentation on the challenges and opportunities sustainability offers the Pharma supply chain.

NAZNEEN RAHMAN CBE | Founder and Chief Executive Officer | YewMaker

13:06 – 13:51

Pharma Supply Chain Roundtable

How can collaboration across the supply chain harness innovation to drive sustainability benefits in pharma development, manufacturing and supply?

speakers

Session 7:

13:56 – 14:09

Manufacturing showcase

A presentation on achieving sustainable pharmaceutical manufacturing.

CHRIS PRICE | Professor of Industrial Crystallization and Isolation | University of Strathclyde

14:15 – 14:28

Manufacturing showcase

A presentation on oligonucleotides

JOHN ARTHUR | Director | Medicines Manufacturing Innovation Centre

14:32 – 14:36

How CPI supports the pharma industry to be more sustainable

FRANK MILLAR | Chief Executive | CPI

Closing Remarks

IVAN McKEE | Minister for Business, Trade, Tourism and Enterprise | The Scottish Government

Sign up for life science integrates news

Get the latest news and updates by signing up today.

By signing up to the life science integrates newsletter, you have read and agree to our Privacy Policy, including our Cookie use.

LIVE ONLINE 24 February 2022

Policy Learning from Cop 26

The COP26 conference united the world to tackle climate change. How can life sciences take the learnings from COP26 forward for the sector?

In our opening session, speakers will set out where we are on tackling climate change from a Government, pharmaceutical industry and academic perspective. They will also look at progress so far, where we want to get to, what still needs to be addressed, and how we can solve these issues.

SPEAKERS

Industry ambition

Sustainability in practice – How is the pharmaceutical industry answering sustainability challenges.

This session will be a ‘deeper dive’ into the sustainability challenge for the pharmaceutical industry, looking at areas like measurement of progress, how to tackle waste and greener chemistry. Input from leading pharmaceutical organisations followed by a panel Q and A.

FACILITATED BY

STEVE HOARE | Quality, Regulatory Science & Safety Policy Director | Association of the British Pharmaceutical Industry

PANELLISTS INCLUDE

Carbon Footprint Showcase: the power of collaboration to deliver sustainable healthcare

The presentation will outline how the Sustainable Healthcare Coalition, a partnership of leading companies and public sector agencies, addresses some of the most pressing sustainability issues in global healthcare by measuring impact.
Case studies will demonstrate how healthcare sector industry partners can help the NHS and other healthcare systems achieve NetZero and bring together clinicians and industry to meet the challenges of improving sustainability through innovation.

Dr FIONA ADSHEAD | Chair | Sustainable Healthcare Coalition

Supply Chain Showcase The Sustainable Medicines Partnership

A presentation on the challenges and opportunities sustainability offers the Pharma supply chain

Every year, billions of effective medicines are discarded unused, or are lost due to packaging or supply chain failures, at huge environmental and financial cost.
To reduce this avoidable waste, YewMaker set-up the Sustainable Medicines Partnership, a multi-stakeholder partnership executing priority actions to make medicines more sustainable and equitable.
In this presentation you will hear about the Pillars of Sustainable Medicines, the SMP Projects and priorities, and how you can get involved.

NAZNEEN RAHMAN CBE | Founder and Chief Executive Officer | YewMaker

Pharma Supply Chain Roundtable

The net zero agenda requires action from all organisations to enable the necessary but challenging targets arising from COP26 to be met. This roundtable will explore the steps being taken across the pharma supply chain to support large pharma companies and healthcare systems to achieve their net zero commitments and discuss opportunities for collaboration to accelerate resource efficiency in the supply chain.

FACILITATED BY

MARK TALFORD | Deputy Challenge Director | Medicines Manufacturing

SPEAKERS INCLUDE

Manufacturing showcase

Achieving sustainable pharmaceutical manufacturing.

The pharmaceutical sector produces around one thousand times more hazardous waste per kg of product than that oil refining, most of this is solvent which is used once and incinerated, it is also a significant consumer of water and energy.

Avenues open to address this include:

Increasing API potency in drug discovery / candidate selection reduces the mass to be manufactured so consuming less resources.
Replacing large scale batch processing capability with low utilisation, with agile and compact continuous process equipment significantly reduces manufacturing footprint and energy consumption, this also increases manufacturing flexibility.
Focusing on minimisation of solvent use by smart solvent selection in process design, by telescoping multiple stages in a single solvent and by application of in process solvent recycling.

CHRIS PRICE | Professor of Industrial Crystallization and Isolation | University of Strathclyde

Manufacturing showcase: a presentation on oligonucleotides

Currently, oligonucleotides are expensive to produce and their utility is limited by inefficiencies inherent in the manufacturing process and the finite quantity of some raw ingredients. Grand Challenge 3 at the Medicines Manufacturing Innovation – a collaboration between CPI, industry, academia and government – aims to revolutionise the oligonucleotide manufacturing process through the development of scalable, liquid phase API processes which will enable oligonucleotides to be manufactured on an industrial scale, more efficiently and at lower cost. By delivering this Grand Challenge, we will enable the industry to provide oligonucleotide therapeutics to much larger patient populations at affordable prices and in a sustainable way.

JOHN ARTHUR | Director | Medicines Manufacturing Innovation Centre

How CPI supports the pharma industry to be more sustainable

In our penultimate session, Frank Millar, CEO of CPI, a deep tech innovation centre, will share his thoughts on what we should be focusing on to ensure that the pharma industry remains grounded in sustainable practises moving forward.

Frank will also discuss collaboration and its role in overcoming major industry hurdles.

FRANK MILLAR | Chief Executive | CPI

LIVE ONLINE 24 February 2022

Pharma Sustainability Integrates 2022 Agenda

24 Feb 2022

KEYNOTES, PANEL DISCUSSIONS AND PRESENTATIONS

THE DAY WILL START WITH OPENING REMARKS AND CONCLUDE AT 14:20.

11:00 – 11:07

Welcome and opening remarks

Session 1

11:10 – 11:31

Policy – Learning from COP26

Session 2

11:31 – 11:36

Decarbonising Pharma supply chains

Session 3

11:40 – 12:25

Industry Ambition Roundtable

Session 4

12:30 – 12:43

Carbon Footprint Showcase:

Session 5

12:48 – 13:01

Supply Chain Showcase:

Session 6

13:06 – 13:51

Pharma Supply Chain Roundtable

Session 7

13:56 – 14:09

Manufacturing showcase:

Session 8

14:15 – 14:28

Manufacturing showcase:

Session 9

14:32 – 14:38

How CPI supports the pharma industry to be more sustainable

14:43 – 14:53

Policy:

11:00 – 11:04

Welcome and opening remarks

Session 1:

11:05 – 11:31

Policy – Learning from COP26

Session 2:

11:31 – 11:36

A Sustainability Presentation

Session 3:

11:40 – 12:25

Industry ambition

Session 4:

12:30 – 12:43

Carbon Footprint Showcase

Session 5:

12:48 – 13:01

Supply Chain Showcase

Session 6:

13:06 – 13:51

Pharma Supply Chain Roundtable

Session 7:

13:56 – 14:09

Manufacturing showcase

Session 7:

14:15 – 14:28

Manufacturing showcase

Session 8:

14:32 – 14:36

How CPI supports the pharma industry to be more sustainable

14:43 – 14:53

Closing Remarks

Sign up for life science integrates news

LIVE ONLINE 24 February 2022

Pharma Sustainability Integrates Agenda 2022

Policy Learning from Cop 26

SPEAKERS

Industry ambition

FACILITATED BY

PANELLISTS INCLUDE

Carbon Footprint Showcase: the power of collaboration to deliver sustainable healthcare

Supply Chain Showcase The Sustainable Medicines Partnership

Pharma Supply Chain Roundtable

FACILITATED BY

SPEAKERS INCLUDE